Consensus Stem, Inc.

Equities

STEM

US85859N1028

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
1.83 ^USD	+10.24%		+18.06%	-52.84%

Apr. 19	Stem, Inc. Appoints Gerard Cunningham as Board of Director	CI
Apr. 11	Piper Sandler Trims Price Target on Stem to $2 From $3, Maintains Neutral Rating	MT

Evolution of the average Target Price on Stem, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f0f6e64ad2b5.awRqLhIzNDQDvR2L-Y5bBl8L0SIJ2PMdfgyq1X32L24.KXQPfHMeAHJy_i7amtwIbWdGlG19qaNxKlXFlB6_bShYQjJaSlxeZnPMeg~6e286661b32d91108e5679501d835242

Analyst Recommendations on Stem, Inc.

Piper Sandler Trims Price Target on Stem to $2 From $3, Maintains Neutral Rating	Apr. 11	MT
Stem Shares Decline Following Downgrade From Goldman Sachs	Mar. 22	MT
Goldman Sachs Downgrades Stem to Neutral From Buy, Cuts Price Target to $2.50 From $5.50	Mar. 22	MT
Susquehanna Trims Price Target on Stem to $4 From $5.50, Maintains Positive Rating	Feb. 29	MT
Morgan Stanley Cuts Price Target on Stem to $4 From $7, Maintains Equal-Weight Rating	Dec. 08	MT
Guggenheim Downgrades Stem to Neutral From Buy	Nov. 03	MT
Roth MKM Adjusts Price Target on Stem to $3.70 From $6, Maintains Neutral Rating	Nov. 01	MT
Barclays Trims Stem's Price Target to $5 From $6, Maintains Equalweight Rating	23-10-24	MT
BNP Paribas Exane Initiates Stem With Neutral Rating, Price Target is $5	23-10-20	MT
Morgan Stanley Trims Price Target on STEM to $7 From $8, Keeps Equalweight Rating	23-10-17	MT
Goldman Sachs Adjusts Price Target on Stem to $7 From $9.50, Maintains Buy Rating	23-10-17	MT
Piper Sandler Trims Stem Price Target to $4 From $5, Maintains Neutral Rating	23-10-06	MT
Goldman Sachs Trims Price Target on Stem to $9.50 From $11, Maintains Buy Rating	23-09-14	MT
Evercore ISI Adjusts Stem's Price Target to $17 From $11, Keeps Outperform Rating	23-09-08	MT
Morgan Stanley Downgrades Stem to Equal Weight From Overweight, Cuts Price Target to $8 From $12	23-09-06	MT
Barclays Starts Stem at Equalweight With $6 Price Target	23-08-30	MT
UBS Adjusts Stem Price Target to $9 From $8, Maintains Buy Rating	23-08-09	MT
Janney Cuts Price Target on Stem to $11 From $12, Keeps Buy Rating	23-08-04	MT
Piper Sandler Initiates Stem With Neutral Rating, $6 Price Target	23-06-23	MT
Janney Initiates Stem at Buy With $12 Price Target	23-06-06	MT
Evercore ISI Group Initiates Stem at Outperform With $11 Price Target	23-05-24	MT
UBS Adjusts Stem Price Target to $8 From $9.50, Maintains Buy Rating	23-05-09	MT
UBS Adjusts Stem Price Target to $9.50 From $18, Maintains Buy Rating	23-04-06	MT
Wolfe Research Downgrades Stem to Peer Perform From Outperform	23-04-06	MT
BofA Securities Downgrades Stem to Underperform From Neutral, Adjusts Price Target to $5 From $9	23-04-04	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.83 USD

Average target price

4.785 USD

Spread / Average Target

+161.45%

High Price Target

13 USD

Spread / Highest target

+610.38%

Low Price Target

2 USD

Spread / Lowest Target

+9.29%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Stem, Inc.

Piper Sandler
Goldman Sachs
Susquehanna
Morgan Stanley
Guggenheim
Roth MKM
Barclays
BNP Paribas Exane
Evercore ISI
UBS
Janney Capital
Wolfe Research
BofA Securities
Credit Suisse
Cowen
Northland Securities

Ratings for Stem, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar